Rakesh Dahiya
Tuesday, August 30, 2022
USFDA issues Form 483 with one observation to Aurobindo Pharma subsidiary's plant
Aurobindo Pharma
https://thehealthmaster.com/?p=40827
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment